<DOC>
	<DOCNO>NCT02042404</DOCNO>
	<brief_summary>The EarLens System assistive hearing device intend provide amplification treatment patient sensorineural hearing impairment . The purpose multi-center definitive study ass safety efficacy EarLens System subject bilateral mild severe sensorineural hearing impairment wear fully activate system daily live 4 month period time . This study design support US International marketing application commercialize EarLens System . The main efficacy hypothesis EarLens System show improve speech understand quiet .</brief_summary>
	<brief_title>The EarLens System Long Term Safety Efficacy Definitive Multi-Center Study</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<criteria>Age 18 85 year Mild severe hear impairment 125 4000 Hz No significant conductive hearing impairment Able willing commit travel time demand study Must know active medical issue would preclude device include : 1. abnormal tympanic membrane 2. abnormal middle ear history prior middle ear surgery tympanostomy tube 3. ear canal anatomy prevents physicians see adequate amount tympanic membrane Must know active medical issue include : 1. history chronic recurrent ear infection past 24 mouth 2. history dizziness and/or vertigo past 24 month 3. take medications/treatments know ototoxic effect 4. rapidly progressive fluctuate hear impairment 5. diagnose compromise immune system Must fit definition vulnerable subject , per FDA regulation 21 CFR Parts 50 56 Must ear canal anatomy preclude manufacture device determine EarLens manufacturing personnel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hearing impairment</keyword>
	<keyword>Hearing loss</keyword>
</DOC>